Suzanne Vernon: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "|first6=" to " | first6 = ")
m (Text replacement - " | last" to " | last")
 
(76 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[File:SuzanneVernon.jpeg|right]]
[[File:SuzanneVernon.jpeg|right]]
'''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/|title=Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref>  
'''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/ | title = Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref>  


From November 2007 to May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/|title=Suzanne D. Vernon Steps Down from Scientific Director Post | date = 2015-04-08 | website = Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/|title=Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref>
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/ | title = Suzanne D. Vernon Steps Down from Scientific Director Post | date = 2015-04-08 | website = Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/ | title = Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref>


From May 1990 to October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news|url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html|title=Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69|last=Grady | first = Denise | date = 2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref>  
From May 1990 to October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news | url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html | title = Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69 | last = Grady | first = Denise | date = 2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref>  


In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal|last=Reeves | first=William C |author-link=William Reeves | last2 = Wagner | first2=Dieter | author-link2= | last3 = Nisenbaum | first3 = Rosane | author-link3= | last4 = Jones | first4=James F | authorlink4 = | last5 = Gurbaxani|first5=Brian | author-link5= | last6 = Solomon | first6=Laura | author-link6= | last7 = Papanicolaou|first7=Dimitris A | last8 = Unger | first8 = Elizabeth R | authorlink8 = Elizabeth Unger | last9 = Vernon | first9 = Suzanne D  | authorlink9 = Suzanne Vernon|date=Dec 2005|title=Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue=|pages=19|doi=10.1186/1741-7015-3-19|issn=1741-7015|quote=|via=}}</ref>
In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal | last = Reeves | first=William C | authorlink = William Reeves | last2 = Wagner | first2=Dieter | author-link2 = | last3 = Nisenbaum | first3 = Rosane | author-link3 = | last4 = Jones | first4 = James F | authorlink4 = | last5 = Gurbaxani | first5 = Brian | author-link5 = | last6 = Solomon | first6 = Laura | author-link6 = | last7 = Papanicolaou | first7 = Dimitris A | last8 = Unger | first8 = Elizabeth R | authorlink8 = Elizabeth Unger | last9 = Vernon | first9 = Suzanne D  | authorlink9 = Suzanne Vernon | date = Dec 2005 | title = Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue=|pages=19|doi=10.1186/1741-7015-3-19|issn=1741-7015|quote=|via=}}</ref>


==Talks and interviews==
==Talks and interviews==
Line 16: Line 16:


==Studies and Articles==
==Studies and Articles==
*2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Cite journal | last1 = Reeves | first1 = W.C. | authorlink = William Reeves | last2 = Lloyd | first2=A. | authorlink2 = Andrew Lloyd | last3 = Vernon | first3=S.D.  | authorlink3 = Suzanne Vernon | last4 = Klimas | first4=N. | authorlink4 = Nancy Klimas | last5 = Jason | first5=L.A. | authorlink5 = Leonard Jason | last6 = Bleijenberg | first6 = G. | authorlink6 = Gijs Bleijenberg | last7 = Evengard | first7=B. | authorlink7 = Birgitta Evengård | last8 = White | first8 = P.D. | authorlink8 = Peter White | last9 = Nisenbaum | first9 = R.|authorlink9=Rosane Nisenbaum | last10 = Unger | first10 = E.|authorlink10=Elizabeth Unger|title=Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=|pages=25|url=https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 | date = 2003|doi=10.1186/1472-6963-3-25}}</ref> - [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)]
*2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Cite journal | last1 = Reeves | first1 = W.C. | authorlink = William Reeves | last2 = Lloyd | first2=A. | authorlink2 = Andrew Lloyd | last3 = Vernon | first3=S.D.  | authorlink3 = Suzanne Vernon | last4 = Klimas | first4 = N. | authorlink4 = Nancy Klimas | last5 = Jason | first5 = L.A. | authorlink5 = Leonard Jason | last6 = Bleijenberg | first6 = G. | authorlink6 = Gijs Bleijenberg | last7 = Evengard | first7 = B. | authorlink7 = Birgitta Evengård | last8 = White | first8 = P.D. | authorlink8 = Peter White | last9 = Nisenbaum | first9 = R. | author-link9 = Rosane Nisenbaum | last10 = Unger | first10 = E. | authorlink10=Elizabeth Unger | title = Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=|pages=25|url=https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 | date = 2003|doi=10.1186/1472-6963-3-25}}</ref> - [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)]
*2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal|last=Whistler | first=Toni | author-link=Toni Whistler | last2 = Unger | first2=Elizabeth R. | authorlink2 = Elizabeth Unger | last3 = Nisenbaum | first3 = Rosane | author-link3=Rosane Nisenbaum | last4 = Vernon | first4=Suzanne D.  | authorlink4 = Suzanne Vernon | author-link5=|date=Dec 1, 2003|title=Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> - [https://doi.org/10.1186/1479-5876-1-10 (Full Text)]
*2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal | last = Whistler | first=Toni | authorlink = Toni Whistler | last2 = Unger | first2=Elizabeth R. | authorlink2 = Elizabeth Unger | last3 = Nisenbaum | first3 = Rosane | author-link3 = Rosane Nisenbaum | last4 = Vernon | first4 = Suzanne D.  | authorlink4 = Suzanne Vernon | author-link5 = | date = Dec 1, 2003 | title = Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> - [https://doi.org/10.1186/1479-5876-1-10 (Full Text)]
*2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal|last=Rajeevan | first = Mangalathu S.|author-link=Mangalathu Rajeevan | last2 = Jones | first2=James F. | authorlink2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Unger | first4=Elizabeth R. | authorlink4 = Elizabeth Unger | last5 = Steinau|first5=Martin | author-link5=|date=2004-11-01|title=Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11 | pages = 750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> - [[pubmed:15490094|(Abstract)]]
*2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal | last = Rajeevan | first = Mangalathu S. | author-link = Mangalathu Rajeevan | last2 = Jones | first2=James F. | authorlink2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Unger | first4 = Elizabeth R. | authorlink4 = Elizabeth Unger | last5 = Steinau | first5 = Martin | author-link5 = | date = 2004-11-01 | title = Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11 | pages = 750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> - [[pubmed:15490094|(Abstract)]]
*2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" />
*2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" />
*2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal|last=Hickie | first = Ian | author-link=Ian Hickie | last2 = Davenport | first2=Tracey | authorlink2 = Tracey Davenport | last3 = Wakefield | first3=Denis|author-link3=Denis Wakefield | last4 = Vollmer-Conna | first4=Ute | authorlink4 = Uté Vollmer-Conna | last5 = Cameron | first5=Barbara | author-link5=Barbara Cameron | last6 = Vernon | first6=Suzanne D  | authorlink6 = Suzanne Vernon | last7 = Reeves | first7=William C  | authorlink7 = William Reeves | last8 = Lloyd | first8 = Andrew | authorlink8 = Andrew Lloyd|date=2006-09-16|title=Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> - [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)]
*2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal | last = Hickie | first = Ian | authorlink = Ian Hickie | last2 = Davenport | first2=Tracey | authorlink2 = Tracey Davenport | last3 = Wakefield | first3=Denis | author-link3 = Denis Wakefield | last4 = Vollmer-Conna | first4 = Ute | authorlink4 = Uté Vollmer-Conna | last5 = Cameron | first5 = Barbara | author-link5 = Barbara Cameron | last6 = Vernon | first6 = Suzanne D  | authorlink6 = Suzanne Vernon | last7 = Reeves | first7 = William C  | authorlink7 = William Reeves | last8 = Lloyd | first8 = Andrew | authorlink8 = Andrew Lloyd | date = 2006-09-16 | title = Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> - [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)]
*2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)]
*2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)]
*2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> - [https://www.sciencedirect.com/science/article/pii/S0888754308001948 (Full Text)]
*2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> - [https://www.sciencedirect.com/science/article/pii/S0888754308001948 (Full Text)]
*2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> - [http://psycnet.apa.org/record/2008-15631-001 (Abstract)]
*2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> - [http://psycnet.apa.org/record/2008-15631-001 (Abstract)]
*2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Sorensen | first = Bristol|author-link= | last2 = Jones | first2=James F | authorlink2 = | last3 = Vernon | first3=Suzanne D | authorlink3 = Suzanne Vernon | last4 = Rajeevan | first4=Mangalathu S  | authorlink4 = Mangalathu Rajeevan | author-link5=|date=Jan 2009|title=Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)]
*2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal | last = Sorensen | first = Bristol | author-link = | last2 = Jones | first2=James F | authorlink2 = | last3 = Vernon | first3=Suzanne D | authorlink3 = Suzanne Vernon | last4 = Rajeevan | first4 = Mangalathu S  | authorlink4 = Mangalathu Rajeevan | author-link5 = | date = Jan 2009 | title = Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)]
*2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> -  
*2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> -  
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck | first = David M. | last2 = Vernon |  first2 = Suzanne D.  | authorlink2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly|author-link3=Kim McCleary | last4 = Bateman | first4=Lucinda | authorlink4 = Lucinda Bateman | last5 = Klimas | first5=Nancy G.|author-link5=Nancy Klimas | last6 = Lapp | first6 = Charles W. | authorlink6 = Charles Lapp | last7 = Peterson | first7=Daniel L. | authorlink7 = Daniel Peterson | last8 = Brown | first8 = James R. | last9 = Remlinger | first9 = Katja S. | last10 = Wilfret | last11 = Gerondelis | first11 = Peter | first10 = David A. | date = 2014 | title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank | url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)]
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal | last = Irlbeck | first = David M. | last2 = Vernon |  first2 = Suzanne D.  | authorlink2 = Suzanne Vernon | last3 = McCleary | first3 = K. Kimberly | author-link3 = Kim McCleary | last4 = Bateman | first4 = Lucinda | authorlink4 = Lucinda Bateman | last5 = Klimas | first5 = Nancy G. | authorlink5 = Nancy Klimas | last6 = Lapp | first6 = Charles W. | authorlink6 = Charles Lapp | last7 = Peterson | first7 = Daniel L. | authorlink7 = Daniel Peterson | last8 = Brown | first8 = James R. | last9 = Remlinger | first9 = Katja S. | last10 = Wilfret | last11 = Gerondelis | first11 = Peter | first10 = David A. | date = 2014 | title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank | url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)]
*2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> -  
*2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> -  
*2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] -  
*2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] -  
*2015, Comparing and contrasting consensus versus empirical domains<ref name="Jason, Kot, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1017344 (Abstract)] -  
*2015, Comparing and contrasting consensus versus empirical domains<ref name="Jason, Kot, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1017344 (Abstract)] -  
*2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)]
*2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)]
*2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal | last1   = Murdock | first1 = KW       | authorlink1 = | last2   = Wang | first2 = XS       | authorlink2 = | last3   = Shi | first3 = Q| authorlink3 = | last4   = Cleeland | first4 = CS       | authorlink4 = | last5 = Fagundes | first5 = CP       | authorlink5 = | last6 = Vernon| first6 = Suzanne D.     | authorlink6 = Suzanne Vernon| title  = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research   | volume = 26  | issue = | pages = 913–921 | date = 2016| pmid   = 27600520 | pmc = PMC5336422 | doi = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> -[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)]
*2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal | last1 = Murdock | first1 = KW | authorlink1 = | last2 = Wang | first2 = XS | authorlink2 = | last3 = Shi | first3 = Q | authorlink3 = | last4 = Cleeland | first4 = CS | authorlink4 = | last5 = Fagundes | first5 = CP | authorlink5 = | last6 = Vernon | first6 = Suzanne D. | authorlink6 = Suzanne Vernon| title  = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research | volume = 26  | issue = | pages = 913–921 | date = 2016| pmid = 27600520 | pmc = PMC5336422 | doi = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)]
*2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal|last=Harvey | first = Jeanna M.|author-link=Jeanna Harvey | last2 = Broderick | first2 = Gordon | author-link2=Gordon Broderick | last3 = Bowie | first3 = Alanna | author-link3=Alanna Bowie | last4 = Barnes | first4=Zachary M. | authorlink4 = Zachary Barnes | last5 = Katz|first5=Ben Z.|author-link5=Ben Katz | last6 = O'Gorman | first6=Maurice R. G. | authorlink6 = Maurice O'Gorman | last7 = Vernon | first7=Suzanne D.  | authorlink7 = Suzanne Vernon | last8 = Fletcher | first8 = Mary Ann | authorlink8 = Mary Ann Fletcher | last9 = Klimas | first9 = Nancy G. | authorlink9 = Nancy Klimas|date=2016-04-26|title=Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote=}}</ref> - [https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-016-0596-8 (Full Text)]
*2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal | last = Harvey | first = Jeanna M. | author-link = Jeanna Harvey | last2 = Broderick | first2 = Gordon | author-link2 = Gordon Broderick | last3 = Bowie | first3 = Alanna | author-link3 = Alanna Bowie | last4 = Barnes | first4 = Zachary M. | authorlink4 = Zachary Barnes | last5 = Katz | first5 = Ben Z. | authorlink5 = Ben Katz | last6 = O'Gorman | first6 = Maurice R.G. | author-link6 = Maurice O'Gorman | last7 = Vernon | first7 = Suzanne D.  | authorlink7 = Suzanne Vernon | last8 = Fletcher | first8 = Mary Ann | authorlink8 = Mary Ann Fletcher | last9 = Klimas | first9 = Nancy G. | authorlink9 = Nancy Klimas | date = 2016-04-26 | title = Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote=}}</ref> - [https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-016-0596-8 (Full Text)]
*2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)]
*2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)]
*2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS]
*2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS]
*2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Landi | first = Abdolamir | author-link=Amir Landi | last2 = Broadhurst | first2=David | author-link2= | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Tyrrell | first4 =  D. Lorne J. | authorlink4 = | last5 = Houghton | first5=Michael|author-link5=Michael Houghton|date=Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)]
*2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal | last = Landi | first = Abdolamir | authorlink = Amir Landi | last2 = Broadhurst | first2=David | author-link2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Tyrrell | first4 =  D. Lorne J. | authorlink4 = | last5 = Houghton | first5 = Michael | author-link5 = Michael Houghton | date = Feb 2016 | title = Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)]
*2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)]
*2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)]
*2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> - [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] -  
*2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> - [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] -  
*2018, A [[C-reactive protein]] response in patients with post-treatment [[Lyme]] Disease symptoms versus those with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Uhde, 2018 May 8" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29741589 (Abstract)]
*2018, A [[C-reactive protein]] response in patients with post-treatment [[Lyme]] Disease symptoms versus those with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Uhde, 2018 May 8" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29741589 (Abstract)]
*2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018">{{Cite journal | last1   = de Vega | first1 = Wilfred C.       | authorlink1 = Wilfred de Vega | last2   = Erdman | first2 = Lauren   | authorlink2 = | last3   = Vernon | first3 = Suzanne D.       | authorlink3 = Suzanne Vernon | last4   = Goldenberg | first4 = Anna     | authorlink4 = | last5 = McGowan | first5 = Patrick O.       | authorlink5 = Patrick McGowan| title  = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome| journal = Epigenomics | volume = 10   | issue = 5 | pages = 539-557 | date = 2018| url = https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 | pmid   = | pmc =  | doi = 10.2217/epi-2017-0150}}</ref> - [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)]
*2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2 = Erdman | first2 = Lauren | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Goldenberg | first4 = Anna| authorlink4 = | last5 = McGowan | first5 = Patrick O. | authorlink5 = Patrick McGowan| title  = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome| journal = Epigenomics | volume = 10 | issue = 5 | pages = 539-557 | date = 2018| url = https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 | pmid = | pmc =  | doi = 10.2217/epi-2017-0150}}</ref> - [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)]
*2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> - [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)]
*2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> - [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)]
*2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|last=Herrera | first=S |author-link= | last2 = de Vega | first2=WC  | authorlink2 = Wilfred de Vega | last3 = Ashbrook | first3 = D | authorlink3 = | last4 = Vernon | first4=SD  | authorlink4 = Suzanne Vernon | last5 = McGowan | first5=PO|author-link5=Patrick McGowan|date=Dec 2018|title=Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|journal=Epigenetics|volume=13|issue=12|pages=1174-1190| url = https://www.ncbi.nlm.nih.gov/pubmed/30516085  | pmid = 30516085 |doi=10.1080/15592294.2018.1549769|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/30516085 (Abstract)]
*2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal | last = Herrera | first = S | authorlink = | last2 = de Vega | first2=WC  | authorlink2 = Wilfred de Vega | last3 = Ashbrook | first3 = D | authorlink3 = | last4 = Vernon | first4 = SD  | authorlink4 = Suzanne Vernon | last5 = McGowan | first5 = PO | authorlink5 = Patrick McGowan | date = Dec 2018 | title = Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|journal=Epigenetics|volume=13|issue=12|pages=1174-1190| url = https://www.ncbi.nlm.nih.gov/pubmed/30516085  | pmid = 30516085 |doi=10.1080/15592294.2018.1549769|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/30516085 (Abstract)]
*2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Karhan | first = Ece | last2 = Gunter | first2=Courtney L | last3 = Ravanmehr | first3=Vida | last4 = Horne | first4 = Meghan | last5 = Kozhaya | first5=Lina | last6 = Renzullo | first6 = Stephanie | last7 = Placek|first7=Lindsey | last8 = George | first8 = Joshy | last9 = Robinson | first9 = Peter N | last10 = Vernon | first10 = Suzanne D.  | authorlink10 = Suzanne Vernon | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Unutmaz | first12 = Derya | authorlink12 = Derya Unutmaz|date=2019-12-26|title=Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)]
*2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Karhan | first = Ece | last2 = Gunter | first2=Courtney L | last3 = Ravanmehr | first3=Vida | last4 = Horne | first4 = Meghan | last5 = Kozhaya | first5 = Lina | last6 = Renzullo | first6 = Stephanie | last7 = Placek | first7 = Lindsey | last8 = George | first8 = Joshy | last9 = Robinson | first9 = Peter N | last10 = Vernon | first10 = Suzanne D.  | authorlink10 = Suzanne Vernon | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Unutmaz | first12 = Derya | authorlink12 = Derya Unutmaz | date = 2019-12-26 | title = Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)]
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last=Lee | first = Jihyun | author-link= | last2 = Vernon |  first2 = Suzanne D.  | authorlink2 = Suzanne Vernon | last3 = Jeys | first3=Patricia | author-link3= | last4 = Ali | first4 = Weam | authorlink4 = | last5 = Campos | first5=Andrea | author-link5= | last6 = Unutmaz | first6 = Derya | author-link6=Derya Unutmaz | last7 = Yellman | first7=Brayden | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman|date=Dec 2020|title=Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc =  7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)]
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal | last = Lee | first = Jihyun | author-link = | last2 = Vernon |  first2 = Suzanne D.  | authorlink2 = Suzanne Vernon | last3 = Jeys | first3=Patricia | author-link3 = | last4 = Ali | first4 = Weam | authorlink4 = | last5 = Campos | first5 = Andrea | author-link5 = | last6 = Unutmaz | first6 = Derya | author-link6 = Derya Unutmaz | last7 = Yellman | first7 = Brayden | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman | date = Dec 2020 | title = Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc =  7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)]


==Online presence==
==Online presence==
Line 58: Line 58:
==References==
==References==
<references>
<references>
<ref name="Aspler, 2008">{{Cite journal | last1   = Aspler | first1 = AL | authorlink1 = | last2   = Bolshin | first2 = C  | authorlink2 = | last3   = Vernon| first3 = SD | authorlink3 = Suzanne Vernon | last4   = Broderick | first4 = G  | authorlink4 = Gordon Broderick | title = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood | journal = Behavioral and Brain Functions   | volume = 4   | issue =  | pages = 44 | date = 2008 | url = https://behavioralandbrainfunctions.biomedcentral.com/articles/10.1186/1744-9081-4-44| pmid = | pmc = | doi = 10.1186/1744-9081-4-44}}</ref>
<ref name="Aspler, 2008">{{Cite journal | last1 = Aspler | first1 = AL | authorlink1 = | last2 = Bolshin | first2 = C  | authorlink2 = | last3 = Vernon | first3 = SD | authorlink3 = Suzanne Vernon | last4 = Broderick | first4 = G  | authorlink4 = Gordon Broderick | title = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood | journal = Behavioral and Brain Functions | volume = 4 | issue =  | pages = 44 | date = 2008 | url = https://behavioralandbrainfunctions.biomedcentral.com/articles/10.1186/1744-9081-4-44 | pmid = | pmc = | doi = 10.1186/1744-9081-4-44}}</ref>
<ref name="Broderick, 2012">{{Cite journal | last1   = Broderick | first1 = Gordon   | authorlink1 = Gordon Broderick | last2   = Katz | first2 = Ben Z   | authorlink2 = Ben Katz | last3   = Fernandes | first3 = Henrique | authorlink3 = | last4   = Fletcher | first4 = Mary Ann | authorlink4 = Mary Ann Fletcher | last5 = Klimas | first5 = Nancy   | authorlink5 = Nancy Klimas | last6 = Smith | first6 = Frederick A   | authorlink6 = | last7 = O'Gorman | first7 = Maurice RG     | authorlink7 = | last8 = Vernon | first8 = Suzanne D     | authorlink8 = Suzanne Vernon | last9 = Taylor | first9 = Renee   | authorlink9 = Renee Taylor | title  = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue | journal = Journal of Translational Medicine   | volume = 10   | issue = | pages = 191 | url = https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-191 | date = 2012
<ref name="Broderick, 2012">{{Cite journal | last1 = Broderick | first1 = Gordon | authorlink1 = Gordon Broderick | last2 = Katz | first2 = Ben Z | authorlink2 = Ben Katz | last3 = Fernandes | first3 = Henrique | authorlink3 = | last4 = Fletcher | first4 = Mary Ann | authorlink4 = Mary Ann Fletcher | last5 = Klimas | first5 = Nancy | authorlink5 = Nancy Klimas | last6 = Smith | first6 = Frederick A | authorlink6 = | last7 = O'Gorman | first7 = Maurice RG | authorlink7 = | last8 = Vernon | first8 = Suzanne D | authorlink8 = Suzanne Vernon | last9 = Taylor | first9 = Renee | authorlink9 = Renee Taylor | title  = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue | journal = Journal of Translational Medicine | volume = 10 | issue = | pages = 191 | url = https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-191 | date = 2012
  | doi = 10.1186/1479-5876-10-191}}</ref>
  | doi = 10.1186/1479-5876-10-191}}</ref>
<ref name="Cook, 2017">{{Cite journal | last1   = Cook | first1 = Dane B.   | authorlink1 = Dane Cook | last2   = Light | first2 = Alan R.   | authorlink2 = Alan Light | last3   = Light | first3 = Kathleen C.       | authorlink3 = Kathleen Light | last4   = Broderick | first4 = Gordon   | authorlink4 = Gordon Broderick | last5 = Shields | first5 = Morgan R. | authorlink5 = | last6 = Dougherty | first6 = Ryan J. | authorlink6 = | last7 = Meyer | first7 = Jacob D.  | authorlink7 = | last8 = VanRiper | first8 = Stephanie | authorlink8 = | last9 = Stegner | first9 = Aaron J.  | authorlink9 = | last10  = Ellingson | first10 = Laura D. | authorlink10 = | last11 = Vernon | first11 = Suzanne D.       | authorlink11 = Suzanne Vernon | title  = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Brain, Behavior, and Immunity   | volume = 62   | issue = | pages =87-99 | url = https://www.sciencedirect.com/science/article/pii/S088915911730051X | date = 2017| pmid   =  | doi = 10.1016/j.bbi.2017.02.009}}</ref>
<ref name="Cook, 2017">{{Cite journal | last1 = Cook | first1 = Dane B. | authorlink1 = Dane Cook | last2 = Light | first2 = Alan R. | authorlink2 = Alan Light | last3 = Light | first3 = Kathleen C. | authorlink3 = Kathleen Light | last4 = Broderick | first4 = Gordon | authorlink4 = Gordon Broderick | last5 = Shields | first5 = Morgan R. | authorlink5 = | last6 = Dougherty | first6 = Ryan J. | authorlink6 = | last7 = Meyer | first7 = Jacob D.  | authorlink7 = | last8 = VanRiper | first8 = Stephanie | authorlink8 = | last9 = Stegner | first9 = Aaron J.  | authorlink9 = | last10  = Ellingson | first10 = Laura D. | authorlink10 = | last11 = Vernon | first11 = Suzanne D. | authorlink11 = Suzanne Vernon | title  = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Brain, Behavior, and Immunity | volume = 62 | issue = | pages =87-99 | url = https://www.sciencedirect.com/science/article/pii/S088915911730051X | date = 2017 | pmid =  | doi = 10.1016/j.bbi.2017.02.009}}</ref>
<ref name="Deftereos, 2016">{{Cite journal | last1   = Deftereos | first1 = S. N.     | authorlink1 = | last2   = Vernon | first2 = S. D.     | authorlink2 = Suzanne Vernon | last3   = Persidis | first3 = A.| authorlink3 = | title  = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey| journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 1 | pages = 39-51 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025  | date = 2016| pmid   =  | doi = 10.1080/21641846.2015.1126025}}</ref>
<ref name="Deftereos, 2016">{{Cite journal | last1 = Deftereos | first1 = S. N. | authorlink1 = | last2 = Vernon | first2 = S. D. | authorlink2 = Suzanne Vernon | last3 = Persidis | first3 = A. | authorlink3 = | title  = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey| journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 1 | pages = 39-51 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025  | date = 2016| pmid =  | doi = 10.1080/21641846.2015.1126025}}</ref>
<ref name="de Vega, 2017">{{Cite journal | last1   = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2   = Herrera | first2 = Santiago   | authorlink2 = | last3   = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4   = McGowan | first4 = Patrick O. | authorlink4 = Patrick McGowan| title  = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = BMC Med Genomics   | volume = 10   | issue =  | pages = 11 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ | date = 2017
<ref name="de Vega, 2017">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | last2 = Herrera | first2 = Santiago | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | last4 = McGowan | first4 = Patrick O. | authorlink4 = Patrick McGowan| title  = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = BMC Med Genomics | volume = 10 | issue =  | pages = 11 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ | date = 2017 | pmid = | pmc = PMC5324230  | doi = 10.1186/s12920-017-0248-3}}</ref>
| pmid   = | pmc = PMC5324230  | doi = 10.1186/s12920-017-0248-3}}</ref>
<ref name="Fuite, 2010">{{Cite journal | last1 = Fuite | first1 = Jim | authorlink1 = | last2 = Vernon | first2 = Suzanne | authorlink2 = Suzanne Vernon | last3 = Broderick | first3 = Gordon | authorlink3 = Gordon Broderick | title = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. | journal = Genomics | url =  https://www.sciencedirect.com/science/article/pii/S0888754308001948 | volume = 92 | issue = 6 | pages = 393-9 | date = 2008 | pmid = 18775774 | pmc =  | doi = 10.1016/j.ygeno.2008.08.008}}</ref>
<ref name="Fuite, 2010">{{Cite journal | last1   = Fuite | first1 = Jim   | authorlink1 = | last2   = Vernon | first2 = Suzanne       | authorlink2 = Suzanne Vernon | last3   = Broderick | first3 = Gordon       | authorlink3 = Gordon Broderick | title = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. | journal = Genomics | url =  https://www.sciencedirect.com/science/article/pii/S0888754308001948 | volume = 92   | issue = 6 | pages = 393-9 | date = 2008 | pmid = 18775774 | pmc =  | doi = 10.1016/j.ygeno.2008.08.008}}</ref>
<ref name="Jason, Kot, 2015">{{Cite journal | last1 = Jason | first1 = LA  | authorlink1 = Leonard Jason | last2 = Kot | first2 = B | authorlink2 = | last3 = Sunnquist | first3 = M | authorlink3 = Madison Sunnquist | last4 = Brown | first4 = A | authorlink4 = Abigail Brown | last5 = Reed | first5 = J | authorlink5 = | last6 = Furst | first6 = J | authorlink6 = | last7 = Newton | first7 = JL  | authorlink7 = Julia Newton | last8 = Strand | first8 = EB  | authorlink8 = Elin Strand | last9 = Vernon | first9 = SD  | authorlink9 = Suzanne Vernon| title  = Comparing and Contrasting Consensus versus Empirical Domains| journal = Fatigue: biomedicine, health & behavior | volume = 3 | issue = 2  | pages = 63-74 | date = 2015 | url = https://pubmed.ncbi.nlm.nih.gov/26977374 | pmid = 26977374  | doi = 10.1080/21641846.2015.1017344}}</ref>
<ref name="Jason, Kot, 2015">{{Cite journal | last1   = Jason | first1 = LA  | authorlink1 = Leonard Jason | last2   = Kot | first2 = B   | authorlink2 = | last3   = Sunnquist | first3 = M   | authorlink3 = Madison Sunnquist | last4   = Brown | first4 = A   | authorlink4 = Abigail Brown | last5 = Reed | first5 = J   | authorlink5 = | last6 = Furst | first6 = J | authorlink6 = | last7 = Newton | first7 = JL  | authorlink7 = Julia Newton | last8 = Strand | first8 = EB  | authorlink8 = Elin Strand | last9 = Vernon | first9 = SD  | authorlink9 = Suzanne Vernon| title  = Comparing and Contrasting Consensus versus Empirical Domains| journal = Fatigue: biomedicine, health & behavior   | volume = 3   | issue = 2  | pages = 63-74 | date = 2015 | url = https://pubmed.ncbi.nlm.nih.gov/26977374| pmid   = 26977374  | doi = 10.1080/21641846.2015.1017344}}</ref>
<ref name="Jason, LA, 2014">{{Cite journal | last1 = Jason | first1 = Leonard A. | authorlink1 = Leonard Jason | last2 = Sunnquist | first2 = Madison  | authorlink2 = Madison Sunnquist | last3 = Brown | first3 = Abigail  | authorlink3 = Abigail Brown | last4 = Evans | first4 = Meredyth | authorlink4 = Meredyth Evans | last5 = Vernon | first5 = Suzanne D. | authorlink5 = Suzanne Vernon | last6 = Furst | first6 = Jacob D. | authorlink6 = | last7 = Simonis | first7 = Valerie  | authorlink7 =  | title = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis | journal = Fatigue: Biomedicine, Health & Behavior | volume = 2 | issue = 1 | pages = 40-56 | date = 2014 | pmid = | pmc =  PMC3912876 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912876/  | doi = 10.1080/21641846.2013.862993}}</ref>
<ref name="Jason, LA, 2014">{{Cite journal | last1   = Jason | first1 = Leonard A.       | authorlink1 = Leonard Jason | last2   = Sunnquist | first2 = Madison  | authorlink2 = Madison Sunnquist | last3   = Brown | first3 = Abigail  | authorlink3 = Abigail Brown | last4   = Evans | first4 = Meredyth | authorlink4 = Meredyth Evans | last5 = Vernon | first5 = Suzanne D.       | authorlink5 = Suzanne Vernon | last6 = Furst | first6 = Jacob D. | authorlink6 = | last7 = Simonis | first7 = Valerie  | authorlink7 =  | title = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis | journal = Fatigue: Biomedicine, Health & Behavior   | volume = 2   | issue = 1 | pages = 40-56 | date = 2014| pmid   = | pmc =  PMC3912876 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912876/  | doi = 10.1080/21641846.2013.862993}}</ref>
<ref name="Jason, Sunn, 2015">{{Cite journal | last1 = Jason | first1 = L.A. | authorlink1 = Leonard Jason | last2 = Sunnquist | first2 = M. | authorlink2 = Madison Sunnquist | last3 = Brown | first3 = A. | authorlink3 = Abigail Brown | last4 = Newton | first4 = J.L. | authorlink4 = Julia Newton | last5 = Strand | first5 = E.B. | authorlink5 = Elin Strand | last6 = Vernon | first6 = S.D. | authorlink6 = Suzanne Vernon | title  = Chronic fatigue syndrome versus systemic exertion intolerance disease| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 3 | pages = 127-141 | date = 2015 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 | pmid =  | doi = 10.1080/21641846.2015.1051291 }}</ref>
<ref name="Jason, Sunn, 2015">{{Cite journal | last1   = Jason | first1 = L.A.       | authorlink1 = Leonard Jason | last2   = Sunnquist | first2 = M. | authorlink2 = Madison Sunnquist | last3   = Brown | first3 = A. | authorlink3 = Abigail Brown | last4   = Newton | first4 = J.L.       | authorlink4 = Julia Newton | last5 = Strand | first5 = E.B.       | authorlink5 = Elin Strand | last6 = Vernon | first6 = S.D.     | authorlink6 = Suzanne Vernon | title  = Chronic fatigue syndrome versus systemic exertion intolerance disease| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 3 | pages = 127-141 | date = 2015| url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 | pmid   =  | doi = 10.1080/21641846.2015.1051291 }}</ref>
<ref name="Shukla, 2015">{{Cite journal | last1 = Shukla | first1 = SK | authorlink1 = | last2 = Cook | first2 = DB | authorlink2 = Dane Cook | last3 = Meyer | first3 = J | authorlink3 = | last4 = Vernon | first4 = SD | authorlink4 = Suzanne Vernon | last5 = Le | first5 = T | authorlink5 = | last6 = Clevidence | first6 = D | authorlink6 = | last7 = Robertson | first7 = CE | authorlink7 = | last8 = Schrodi | first8 = SJ | authorlink8 = | last9 = Yale | first9 = S | authorlink9 = | last10  = Frank | first10 = DN | authorlink10 = | title = Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal =  PLoS One | volume = 10 | issue = 12 | pages = e0145453 | date = 2015 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203 | pmid = | pmc = PMC468420  | doi = 10.1371/journal.pone.0145453 }}</ref>
<ref name="Shukla, 2015">{{Cite journal | last1   = Shukla | first1 = SK     | authorlink1 = | last2   = Cook | first2 = DB     | authorlink2 = Dane Cook | last3   = Meyer | first3 = J       | authorlink3 = | last4   = Vernon | first4 = SD     | authorlink4 = Suzanne Vernon | last5 = Le | first5 = T       | authorlink5 = | last6 = Clevidence | first6 = D     | authorlink6 = | last7 = Robertson | first7 = CE   | authorlink7 = | last8 = Schrodi | first8 = SJ   | authorlink8 = | last9 = Yale | first9 = S       | authorlink9 = | last10  = Frank | first10 = DN     | authorlink10 = | title = Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal =  PLoS One   | volume = 10   | issue = 12 | pages = e0145453 | date = 2015| url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203 | pmid   = | pmc = PMC468420  | doi = 10.1371/journal.pone.0145453 }}</ref>
<ref name="Uhde, 2018">{{Cite journal | last1 = Uhde | first1 = M  | authorlink1 = | last2 = Indart | first2 = AC | authorlink2 = | last3 = Yu | first3 = XB | authorlink3 = | last4 = Jang | first4 = SS | authorlink4 = | last5 = De Giorgio | first5 = R  | authorlink5 = | last6 = Green | first6 = PHR | authorlink6 = | last7 = Volta | first7 = U  | authorlink7 = | last8 = Vernon | first8 = SD | authorlink8 = Suzanne Vernon | last9 = Alaedini | first9 = A  | authorlink9 =  | title = Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome| journal = Gut | volume = 68 | issue =  | pages = 377-378 | url = https://gut.bmj.com/content/68/2/377 | date = 2018 | pmid =  | doi = 10.1136/gutjnl-2018-316133}}</ref>
<ref name="Uhde, 2018">{{Cite journal | last1   = Uhde | first1 = M  | authorlink1 = | last2   = Indart | first2 = AC | authorlink2 = | last3   = Yu | first3 = XB | authorlink3 = | last4   = Jang | first4 = SS | authorlink4 = | last5 = De Giorgio | first5 = R  | authorlink5 = | last6 = Green | first6 = PHR| authorlink6 = | last7 = Volta | first7 = U  | authorlink7 = | last8 = Vernon | first8 = SD | authorlink8 = Suzanne Vernon | last9 = Alaedini | first9 = A  | authorlink9 =  | title = Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome| journal = Gut | volume = 68 | issue =  | pages = 377-378 | url = https://gut.bmj.com/content/68/2/377 | date = 2018
<ref name="Uhde, 2018 May 8">{{Cite journal | last1 = Uhde | first1 = M  | authorlink1 = | last2 = Indart | first2 = AC | authorlink2 = | last3 = Fallon | first3 = BA | authorlink3 = | last4 = Wormser | first4 = GP | authorlink4 = | last5 = Marques | first5 = AR | authorlink5 = | last6 = Vernon | first6 = SD | authorlink6 = Suzanne Vernon | last7 = Alaedini | first7 = A  | authorlink7 =  | title = C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Clin Infect Dis | volume = 67  | issue =  8 | pages = 1309-1310 | pmc = PMC6160605 | date = 2018 | pmid = 29741589 | url = https://pubmed.ncbi.nlm.nih.gov/29741589 | doi = 10.1093/cid/ciy299}}</ref>
| pmid   =  | doi = 10.1136/gutjnl-2018-316133}}</ref>
<ref name="Vernon, 2006">{{Cite journal | last1 = Vernon | first1 = SD | authorlink1 = Suzanne Vernon | last2 = Whistler | first2 = T  | authorlink2 = | last3 = Cameron | first3 = B  | authorlink3 = | last4 = Hickie | first4 = IB | authorlink4 = Ian Hickie | last5 = Reeves | first5 = WC | authorlink5 = William Reeves | last6 = Lloyd | first6 = A  | authorlink6 = Andrew Lloyd| title  = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus| journal = BMC Infectious Diseases | volume = 6 | issue = 15 | pages = | date = 2006 | pmid = 16448567 | url = https://pubmed.ncbi.nlm.nih.gov/16448567 | doi = 10.1186/1471-2334-6-15}}</ref>
<ref name="Uhde, 2018 May 8">{{Cite journal | last1   = Uhde | first1 = M  | authorlink1 = | last2   = Indart | first2 = AC | authorlink2 = | last3   = Fallon| first3 = BA | authorlink3 = | last4   = Wormser | first4 = GP | authorlink4 = | last5 = Marques | first5 = AR | authorlink5 = | last6 = Vernon| first6 = SD | authorlink6 = Suzanne Vernon | last7 = Alaedini | first7 = A  | authorlink7 =  | title = C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Clin Infect Dis | volume = 67  | issue =  8 | pages = 1309-1310 | pmc = PMC6160605 | date = 2018| pmid   = 29741589 | url = https://pubmed.ncbi.nlm.nih.gov/29741589| doi  = 10.1093/cid/ciy299}}</ref>
<ref name="Vernon, 2006">{{Cite journal | last1   = Vernon | first1 = SD | authorlink1 = Suzanne Vernon | last2   = Whistler | first2 = T  | authorlink2 = | last3   = Cameron | first3 = B  | authorlink3 = | last4   = Hickie | first4 = IB | authorlink4 = Ian Hickie | last5 = Reeves | first5 = WC | authorlink5 = William Reeves | last6 = Lloyd | first6 = A  | authorlink6 = Andrew Lloyd| title  = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus| journal = BMC Infectious Diseases   | volume = 6   | issue = 15 | pages = | date = 2006 | pmid   = 16448567 | url = https://pubmed.ncbi.nlm.nih.gov/16448567 | doi = 10.1186/1471-2334-6-15}}</ref>
</references>
</references>


[[Category:Researchers]]
[[Category:Researchers]]
[[Category:US researchers]]
[[Category:US researchers]]

Latest revision as of 14:49, April 3, 2023

SuzanneVernon.jpeg

Suzanne D. Vernon, PhD, is the Research Liaison at Bateman Horne Center of Excellence which specializes in treatment and research for ME/CFS and Fibromyalgia[1] and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of microbiome samples for research and development.[2]

From November 2007 to May 2015, Dr. Vernon was the Scientific Director of Solve ME/CFS Initiative, formerly known as CFIDS Association of America.[3] While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.[1] The core of RIWW is the SolveCFS BioBank & Patient Registry.[4]

From May 1990 to October 2007, Dr. Vernon worked for the US Centers for Disease Control, first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under William Reeves, MD, the Director of the CDC Chronic Fatigue Research Program.[5][6]

In 2005, Dr Vernon was one of the authors of the CDC case definition of CFS, commonly called the Reeves criteria.[7]

Talks and interviews[edit | edit source]

Studies and Articles[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 "Suzanne D. Vernon, PhD". Bateman Horne Center. Retrieved February 2, 2019.
  2. http://www.thebiocollective.com/about-us/
  3. "Suzanne D. Vernon Steps Down from Scientific Director Post". Solve ME/CFS Initiative. April 8, 2015. Retrieved February 2, 2019.
  4. "Advancing Science: A Case for Hope, A Look Ahead". Solve ME/CFS Initiative. Retrieved June 25, 2019.
  5. https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617
  6. Grady, Denise (August 8, 2012). "Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69". The New York Times. ISSN 0362-4331. Retrieved February 2, 2019.
  7. 7.0 7.1 Reeves, William C; Wagner, Dieter; Nisenbaum, Rosane; Jones, James F; Gurbaxani, Brian; Solomon, Laura; Papanicolaou, Dimitris A; Unger, Elizabeth R; Vernon, Suzanne D (December 2005). "Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study". BMC Medicine. 3: 19. doi:10.1186/1741-7015-3-19. ISSN 1741-7015.
  8. Reeves, W.C.; Lloyd, A.; Vernon, S.D.; Klimas, N.; Jason, L.A.; Bleijenberg, G.; Evengard, B.; White, P.D.; Nisenbaum, R.; Unger, E. (2003). "Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution". BMC Health Services Research. 3: 25. doi:10.1186/1472-6963-3-25.
  9. Whistler, Toni; Unger, Elizabeth R.; Nisenbaum, Rosane; Vernon, Suzanne D. (December 1, 2003). "Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome". Journal of Translational Medicine. 1: 10. doi:10.1186/1479-5876-1-10. ISSN 1479-5876. PMC 305360. PMID 14641939.
  10. Rajeevan, Mangalathu S.; Jones, James F.; Vernon, Suzanne D.; Unger, Elizabeth R.; Steinau, Martin (November 1, 2004). "Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome". Journal of Molecular Medicine. 82 (11): 750–755. doi:10.1007/s00109-004-0586-4. ISSN 1432-1440.
  11. Hickie, Ian; Davenport, Tracey; Wakefield, Denis; Vollmer-Conna, Ute; Cameron, Barbara; Vernon, Suzanne D; Reeves, William C; Lloyd, Andrew (September 16, 2006). "Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study". BMJ. 333 (7568): 575–. doi:10.1136/bmj.38933.585764.ae. PMC 1569956. PMID 16950834.
  12. Vernon, SD; Whistler, T; Cameron, B; Hickie, IB; Reeves, WC; Lloyd, A (2006). "Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus". BMC Infectious Diseases. 6 (15). doi:10.1186/1471-2334-6-15. PMID 16448567.
  13. Fuite, Jim; Vernon, Suzanne; Broderick, Gordon (2008). "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis". Genomics. 92 (6): 393–9. doi:10.1016/j.ygeno.2008.08.008. PMID 18775774.
  14. Aspler, AL; Bolshin, C; Vernon, SD; Broderick, G (2008). "Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood". Behavioral and Brain Functions. 4: 44. doi:10.1186/1744-9081-4-44.
  15. Sorensen, Bristol; Jones, James F; Vernon, Suzanne D; Rajeevan, Mangalathu S (January 2009). "Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome". Molecular Medicine. 15 (1–2): 34–42. doi:10.2119/molmed.2008.00098. PMC 2583111. PMID 19015737.
  16. Broderick, Gordon; Katz, Ben Z; Fernandes, Henrique; Fletcher, Mary Ann; Klimas, Nancy; Smith, Frederick A; O'Gorman, Maurice RG; Vernon, Suzanne D; Taylor, Renee (2012). "Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue". Journal of Translational Medicine. 10: 191. doi:10.1186/1479-5876-10-191.
  17. Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
  18. Jason, Leonard A.; Sunnquist, Madison; Brown, Abigail; Evans, Meredyth; Vernon, Suzanne D.; Furst, Jacob D.; Simonis, Valerie (2014). "Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis". Fatigue: Biomedicine, Health & Behavior. 2 (1): 40–56. doi:10.1080/21641846.2013.862993. PMC 3912876.
  19. Jason, L.A.; Sunnquist, M.; Brown, A.; Newton, J.L.; Strand, E.B.; Vernon, S.D. (2015). "Chronic fatigue syndrome versus systemic exertion intolerance disease". Fatigue: Biomedicine, Health & Behavior. 3 (3): 127–141. doi:10.1080/21641846.2015.1051291.
  20. Jason, LA; Kot, B; Sunnquist, M; Brown, A; Reed, J; Furst, J; Newton, JL; Strand, EB; Vernon, SD (2015). "Comparing and Contrasting Consensus versus Empirical Domains". Fatigue: biomedicine, health & behavior. 3 (2): 63–74. doi:10.1080/21641846.2015.1017344. PMID 26977374.
  21. Shukla, SK; Cook, DB; Meyer, J; Vernon, SD; Le, T; Clevidence, D; Robertson, CE; Schrodi, SJ; Yale, S; Frank, DN (2015). "Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". PLoS One. 10 (12): e0145453. doi:10.1371/journal.pone.0145453. PMC 468420.
  22. Murdock, KW; Wang, XS; Shi, Q; Cleeland, CS; Fagundes, CP; Vernon, Suzanne D. (2016). "The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome". Quality of Life Research. 26: 913–921. doi:10.1007/s11136-016-1406-3. PMC 5336422. PMID 27600520.
  23. Harvey, Jeanna M.; Broderick, Gordon; Bowie, Alanna; Barnes, Zachary M.; Katz, Ben Z.; O'Gorman, Maurice R.G.; Vernon, Suzanne D.; Fletcher, Mary Ann; Klimas, Nancy G. (April 26, 2016). "Tracking post-infectious fatigue in clinic using routine Lab tests". BMC Pediatrics. 15: 54. doi:10.1186/s12887-016-0596-8. ISSN 1471-2431. PMC 4847210. PMID 27118537.
  24. Deftereos, S. N.; Vernon, S. D.; Persidis, A. (2016). "Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey". Fatigue: Biomedicine, Health & Behavior. 4 (1): 39–51. doi:10.1080/21641846.2015.1126025.
  25. Landi, Abdolamir; Broadhurst, David; Vernon, Suzanne D.; Tyrrell, D. Lorne J.; Houghton, Michael (February 2016). "Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome". Cytokine. 78: 27–36. doi:10.1016/j.cyto.2015.11.018.
  26. de Vega, Wilfred C.; Herrera, Santiago; Vernon, Suzanne D.; McGowan, Patrick O. (2017). "Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". BMC Med Genomics. 10: 11. doi:10.1186/s12920-017-0248-3. PMC 5324230.
  27. Cook, Dane B.; Light, Alan R.; Light, Kathleen C.; Broderick, Gordon; Shields, Morgan R.; Dougherty, Ryan J.; Meyer, Jacob D.; VanRiper, Stephanie; Stegner, Aaron J.; Ellingson, Laura D.; Vernon, Suzanne D. (2017). "Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Brain, Behavior, and Immunity. 62: 87–99. doi:10.1016/j.bbi.2017.02.009.
  28. Uhde, M; Indart, AC; Fallon, BA; Wormser, GP; Marques, AR; Vernon, SD; Alaedini, A (2018). "C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Clin Infect Dis. 67 (8): 1309–1310. doi:10.1093/cid/ciy299. PMC 6160605. PMID 29741589.
  29. de Vega, Wilfred C.; Erdman, Lauren; Vernon, Suzanne D.; Goldenberg, Anna; McGowan, Patrick O. (2018). "Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome". Epigenomics. 10 (5): 539–557. doi:10.2217/epi-2017-0150.
  30. Uhde, M; Indart, AC; Yu, XB; Jang, SS; De Giorgio, R; Green, PHR; Volta, U; Vernon, SD; Alaedini, A (2018). "Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome". Gut. 68: 377–378. doi:10.1136/gutjnl-2018-316133.
  31. Herrera, S; de Vega, WC; Ashbrook, D; Vernon, SD; McGowan, PO (December 2018). "Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Epigenetics. 13 (12): 1174–1190. doi:10.1080/15592294.2018.1549769. PMID 30516085.
  32. Karhan, Ece; Gunter, Courtney L; Ravanmehr, Vida; Horne, Meghan; Kozhaya, Lina; Renzullo, Stephanie; Placek, Lindsey; George, Joshy; Robinson, Peter N; Vernon, Suzanne D.; Bateman, Lucinda; Unutmaz, Derya (December 26, 2019). "Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". biorxiv. doi:10.1101/2019.12.23.887505.
  33. Lee, Jihyun; Vernon, Suzanne D.; Jeys, Patricia; Ali, Weam; Campos, Andrea; Unutmaz, Derya; Yellman, Brayden; Bateman, Lucinda (December 2020). "Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients". Journal of Translational Medicine. 18 (1): 314. doi:10.1186/s12967-020-02481-y. ISSN 1479-5876. PMC 7429890. PMID 32799889.